Canton Hathaway’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $186K | Buy |
515
+300
| +140% | +$103K | 0.04% | 128 |
|
|
2026
Q1 | $75.6K | Hold |
215
| – | – | 0.02% | 166 |
|
|
2025
Q4 | $70.4K | Hold |
215
| – | – | 0.01% | 179 |
|
|
2025
Q3 | $61K | Hold |
215
| – | – | 0.01% | 194 |
|
|
2025
Q2 | $60K | Hold |
215
| – | – | 0.01% | 188 |
|
|
2025
Q1 | $67K | Hold |
215
| – | – | 0.01% | 183 |
|
|
2024
Q4 | $56K | Hold |
215
| – | – | 0.01% | 154 |
|
|
2024
Q3 | $69K | Hold |
215
| – | – | 0.02% | 139 |
|
|
2024
Q2 | $67K | Hold |
215
| – | – | 0.02% | 144 |
|
|
2024
Q1 | $61K | Hold |
215
| – | – | 0.02% | 141 |
|
|
2023
Q4 | $62K | Hold |
215
| – | – | 0.02% | 141 |
|
|
2023
Q3 | $58K | Hold |
215
| – | – | 0.02% | 136 |
|
|
2023
Q2 | $48K | Hold |
215
| – | – | 0.02% | 160 |
|
|
2023
Q1 | $52K | Hold |
215
| – | – | 0.02% | 148 |
|
|
2022
Q4 | $56K | Hold |
215
| – | – | 0.02% | 154 |
|
|
2022
Q3 | $48K | Hold |
215
| – | – | 0.02% | 155 |
|
|
2022
Q2 | $52K | Hold |
215
| – | – | 0.02% | 159 |
|
|
2022
Q1 | $52K | Hold |
215
| – | – | 0.01% | 178 |
|
|
2021
Q4 | $48K | Sell |
215
-11,326
| -98% | -$2.39M | 0.01% | 188 |
|
|
2021
Q3 | $2.45M | Sell |
11,541
-2,125
| -16% | -$489K | 0.71% | 27 |
|
|
2021
Q2 | $3.33M | Buy |
13,666
+469
| +4% | +$115K | 0.97% | 19 |
|
|
2021
Q1 | $3.28M | Buy |
13,197
+147
| +1% | +$35.1K | 1.05% | 16 |
|
|
2020
Q4 | $3M | Buy |
13,050
+291
| +2% | +$67.1K | 1.01% | 16 |
|
|
2020
Q3 | $3.24M | Buy |
12,759
+480
| +4% | +$119K | 1.33% | 7 |
|
|
2020
Q2 | $2.9M | Buy |
12,279
+700
| +6% | +$160K | 1.89% | 6 |
|
|
2020
Q1 | $2.35M | Sell |
11,579
-1,044
| -8% | -$228K | 1.67% | 6 |
|
|
2019
Q4 | $3.04M | Buy |
12,623
+616
| +5% | +$136K | 1.56% | 5 |
|
|
2019
Q3 | $2.32M | Buy |
12,007
+626
| +6% | +$120K | 1.29% | 8 |
|
|
2019
Q2 | $2.1M | Sell |
11,381
-13
| -0.1% | -$2.33K | 1.17% | 10 |
|
|
2019
Q1 | $2.16M | Buy |
11,394
+1,574
| +16% | +$301K | 1.26% | 8 |
|
|
2018
Q4 | $1.91M | Buy |
9,820
+1,050
| +12% | +$205K | 1.24% | 5 |
|
|
2018
Q3 | $1.82M | Buy |
+8,770
| New | +$1.73M | 1.14% | 5 |
|
Other funds holding AMGN
Canton Hathaway's AMGN Position: Q2 2026 in Review
Canton Hathaway increased its Amgen (AMGN) stake by 140% in Q2 2026, buying an estimated $103K and bringing the position to 515 shares worth $186K. The position accounts for 0.04% of the portfolio, ranked #128.
Canton Hathaway first reported a position in AMGN in Q3 2018 and has held it in 32 quarters since. The position peaked at $3.33M in Q2 2021. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Canton Hathaway held 515 shares of Amgen worth $186K as of Q2 2026.
- Canton Hathaway bought 300 Amgen shares in Q2 2026, an estimated $103K.
- Amgen made up 0.04% of Canton Hathaway's portfolio in Q2 2026, its #128 holding.
- Canton Hathaway first reported a position in Amgen in Q3 2018 and has held it in 32 quarters since.
- Canton Hathaway's Amgen position peaked at $3.33M in Q2 2021.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Canton Hathaway's 13F filing for Q2 2026, filed 6 Aug 2026.